ePrints

Venetoclax enhances the efficacy of therapeutic antibodies in B-cell malignancies by augmenting tumor cell phagocytosis

Lookup NU author(s): Dr Simon BomkenORCiD

Downloads

• Published version [.pdf]

Licence

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND).

Publication metadata

Author(s): Vogiatzi F, Heymann J, Müller K, Winterberg D, Drakul A, Rösner T, Lenk L, Heib M, Gehlert CL, Cario G, Schrappe M, Claviez A, Bornhauser B, Bourquin JP, Bomken S, Adam D, Frielitz FS, Maecker-Kolhoff B, Stanulla M, Valerius T, Peipp M, Kellner C, Schewe DM

Publication type: Article

Publication status: Published

Journal: Blood Advances

Year: 2022

Volume: 6

Issue: 16

Pages: 4847–4858

Print publication date: 23/08/2022

Online publication date: 12/07/2022

Acceptance date: 01/07/2022

Date deposited: 06/12/2022

ISSN (print): 2473-9529

ISSN (electronic): 2473-9537

Publisher: American Society of Hematology

URL: https://doi.org/10.1182/bloodadvances.2022007364

DOI: 10.1182/bloodadvances.2022007364

PubMed id: 35820018

Altmetrics

Funding

Share